4//SEC Filing
Fenton Mary Kay 4
Accession 0000950170-24-050844
CIK 0001789972other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 9:02 PM ET
Size
5.8 KB
Accession
0000950170-24-050844
Insider Transaction Report
Form 4
Fenton Mary Kay
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-29+200,000→ 200,000 totalExercise: $27.12Exp: 2034-04-29→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, 25% of which will become vested and exercisable on April 29, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Cullinan Therapeutics, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001378589
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 9:02 PM ET
- Size
- 5.8 KB